nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—SLC22A11—Furosemide—dilated cardiomyopathy	0.128	0.191	CbGbCtD
Indomethacin—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.125	0.187	CbGbCtD
Indomethacin—ABCC2—Spironolactone—dilated cardiomyopathy	0.103	0.155	CbGbCtD
Indomethacin—SLC22A8—Furosemide—dilated cardiomyopathy	0.0743	0.111	CbGbCtD
Indomethacin—ABCC2—Furosemide—dilated cardiomyopathy	0.0707	0.106	CbGbCtD
Indomethacin—SLC22A6—Furosemide—dilated cardiomyopathy	0.0517	0.0773	CbGbCtD
Indomethacin—ALB—Furosemide—dilated cardiomyopathy	0.0441	0.0659	CbGbCtD
Indomethacin—ABCB1—Lisinopril—dilated cardiomyopathy	0.0383	0.0573	CbGbCtD
Indomethacin—ABCB1—Spironolactone—dilated cardiomyopathy	0.0337	0.0504	CbGbCtD
Indomethacin—CYP2C9—cardial valve—dilated cardiomyopathy	0.01	0.139	CbGeAlD
Indomethacin—PTGR2—cardiac ventricle—dilated cardiomyopathy	0.00487	0.0676	CbGeAlD
Indomethacin—PTGDR2—heart—dilated cardiomyopathy	0.00482	0.0668	CbGeAlD
Indomethacin—PTGR2—myocardium—dilated cardiomyopathy	0.00458	0.0635	CbGeAlD
Indomethacin—Uremia—Lisinopril—dilated cardiomyopathy	0.004	0.0294	CcSEcCtD
Indomethacin—PTGR2—heart—dilated cardiomyopathy	0.0032	0.0444	CbGeAlD
Indomethacin—GLO1—cardiac ventricle—dilated cardiomyopathy	0.00301	0.0417	CbGeAlD
Indomethacin—GLO1—myocardium—dilated cardiomyopathy	0.00283	0.0393	CbGeAlD
Indomethacin—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.00283	0.0208	CcSEcCtD
Indomethacin—PLA2G2A—cardiac ventricle—dilated cardiomyopathy	0.0028	0.0388	CbGeAlD
Indomethacin—PTGR2—cardiac atrium—dilated cardiomyopathy	0.00274	0.0379	CbGeAlD
Indomethacin—PLA2G2A—myocardium—dilated cardiomyopathy	0.00263	0.0365	CbGeAlD
Indomethacin—Ulcer—Spironolactone—dilated cardiomyopathy	0.00262	0.0192	CcSEcCtD
Indomethacin—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00254	0.0186	CcSEcCtD
Indomethacin—PPARA—myocardium—dilated cardiomyopathy	0.00246	0.0341	CbGeAlD
Indomethacin—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00243	0.0179	CcSEcCtD
Indomethacin—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00222	0.0163	CcSEcCtD
Indomethacin—AKR1C3—cardiac ventricle—dilated cardiomyopathy	0.00217	0.0301	CbGeAlD
Indomethacin—AKR1C3—myocardium—dilated cardiomyopathy	0.00204	0.0283	CbGeAlD
Indomethacin—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.002	0.0147	CcSEcCtD
Indomethacin—GLO1—heart—dilated cardiomyopathy	0.00198	0.0274	CbGeAlD
Indomethacin—Azotaemia—Lisinopril—dilated cardiomyopathy	0.0019	0.0139	CcSEcCtD
Indomethacin—Apathy—Furosemide—dilated cardiomyopathy	0.00189	0.0139	CcSEcCtD
Indomethacin—Flat affect—Furosemide—dilated cardiomyopathy	0.00187	0.0137	CcSEcCtD
Indomethacin—PLA2G2A—heart—dilated cardiomyopathy	0.00184	0.0255	CbGeAlD
Indomethacin—CXCL8—heart—dilated cardiomyopathy	0.00182	0.0252	CbGeAlD
Indomethacin—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00176	0.0129	CcSEcCtD
Indomethacin—PPARA—heart—dilated cardiomyopathy	0.00172	0.0238	CbGeAlD
Indomethacin—GLO1—cardiac atrium—dilated cardiomyopathy	0.00169	0.0234	CbGeAlD
Indomethacin—Glycosuria—Furosemide—dilated cardiomyopathy	0.00166	0.0122	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00162	0.0119	CcSEcCtD
Indomethacin—Gastritis—Spironolactone—dilated cardiomyopathy	0.00159	0.0117	CcSEcCtD
Indomethacin—PLA2G2A—cardiac atrium—dilated cardiomyopathy	0.00157	0.0218	CbGeAlD
Indomethacin—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.0015	0.011	CcSEcCtD
Indomethacin—Heartburn—Lisinopril—dilated cardiomyopathy	0.00147	0.0108	CcSEcCtD
Indomethacin—Gout—Furosemide—dilated cardiomyopathy	0.00144	0.0106	CcSEcCtD
Indomethacin—AKR1C3—heart—dilated cardiomyopathy	0.00143	0.0198	CbGeAlD
Indomethacin—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00139	0.0102	CcSEcCtD
Indomethacin—Vasculitis—Furosemide—dilated cardiomyopathy	0.00138	0.0101	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00137	0.0101	CcSEcCtD
Indomethacin—Renal failure—Spironolactone—dilated cardiomyopathy	0.00136	0.01	CcSEcCtD
Indomethacin—PPARG—myocardium—dilated cardiomyopathy	0.00135	0.0187	CbGeAlD
Indomethacin—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00129	0.0095	CcSEcCtD
Indomethacin—CES1—heart—dilated cardiomyopathy	0.00127	0.0177	CbGeAlD
Indomethacin—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00126	0.00929	CcSEcCtD
Indomethacin—AKR1C3—cardiac atrium—dilated cardiomyopathy	0.00122	0.0169	CbGeAlD
Indomethacin—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00121	0.00885	CcSEcCtD
Indomethacin—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00118	0.00864	CcSEcCtD
Indomethacin—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00115	0.00845	CcSEcCtD
Indomethacin—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00113	0.00833	CcSEcCtD
Indomethacin—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00113	0.0083	CcSEcCtD
Indomethacin—Alopecia—Spironolactone—dilated cardiomyopathy	0.0011	0.00807	CcSEcCtD
Indomethacin—Oliguria—Lisinopril—dilated cardiomyopathy	0.0011	0.00806	CcSEcCtD
Indomethacin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00109	0.00803	CcSEcCtD
Indomethacin—Deafness—Furosemide—dilated cardiomyopathy	0.00109	0.00803	CcSEcCtD
Indomethacin—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00108	0.00796	CcSEcCtD
Indomethacin—Gout—Lisinopril—dilated cardiomyopathy	0.00108	0.00795	CcSEcCtD
Indomethacin—ABCC1—myocardium—dilated cardiomyopathy	0.00105	0.0145	CbGeAlD
Indomethacin—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00104	0.00761	CcSEcCtD
Indomethacin—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00104	0.00761	CcSEcCtD
Indomethacin—Purpura—Furosemide—dilated cardiomyopathy	0.00101	0.00745	CcSEcCtD
Indomethacin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.001	0.00738	CcSEcCtD
Indomethacin—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000993	0.00729	CcSEcCtD
Indomethacin—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000982	0.00721	CcSEcCtD
Indomethacin—Malaise—Spironolactone—dilated cardiomyopathy	0.000976	0.00717	CcSEcCtD
Indomethacin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000969	0.00712	CcSEcCtD
Indomethacin—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00096	0.00705	CcSEcCtD
Indomethacin—PPARG—heart—dilated cardiomyopathy	0.000944	0.0131	CbGeAlD
Indomethacin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00091	0.00669	CcSEcCtD
Indomethacin—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000904	0.00664	CcSEcCtD
Indomethacin—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.0009	0.00661	CcSEcCtD
Indomethacin—Confusional state—Spironolactone—dilated cardiomyopathy	0.000891	0.00654	CcSEcCtD
Indomethacin—ALB—heart—dilated cardiomyopathy	0.000886	0.0123	CbGeAlD
Indomethacin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000883	0.00649	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000881	0.00647	CcSEcCtD
Indomethacin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000865	0.00635	CcSEcCtD
Indomethacin—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000862	0.00634	CcSEcCtD
Indomethacin—ABCC4—heart—dilated cardiomyopathy	0.000857	0.0119	CbGeAlD
Indomethacin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000851	0.00625	CcSEcCtD
Indomethacin—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000828	0.00608	CcSEcCtD
Indomethacin—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000813	0.00597	CcSEcCtD
Indomethacin—Somnolence—Spironolactone—dilated cardiomyopathy	0.000785	0.00577	CcSEcCtD
Indomethacin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000781	0.00574	CcSEcCtD
Indomethacin—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000771	0.00566	CcSEcCtD
Indomethacin—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000762	0.0056	CcSEcCtD
Indomethacin—Drowsiness—Furosemide—dilated cardiomyopathy	0.000754	0.00554	CcSEcCtD
Indomethacin—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000752	0.00552	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000747	0.00549	CcSEcCtD
Indomethacin—Renal failure—Furosemide—dilated cardiomyopathy	0.000741	0.00544	CcSEcCtD
Indomethacin—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000737	0.00541	CcSEcCtD
Indomethacin—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000734	0.00539	CcSEcCtD
Indomethacin—Diplopia—Lisinopril—dilated cardiomyopathy	0.000734	0.00539	CcSEcCtD
Indomethacin—ABCC1—heart—dilated cardiomyopathy	0.000731	0.0101	CbGeAlD
Indomethacin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000728	0.00535	CcSEcCtD
Indomethacin—PTGS1—myocardium—dilated cardiomyopathy	0.000723	0.01	CbGeAlD
Indomethacin—Sweating—Furosemide—dilated cardiomyopathy	0.000722	0.00531	CcSEcCtD
Indomethacin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000703	0.00517	CcSEcCtD
Indomethacin—Urticaria—Spironolactone—dilated cardiomyopathy	0.000702	0.00516	CcSEcCtD
Indomethacin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000698	0.00513	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000661	0.00485	CcSEcCtD
Indomethacin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000651	0.00478	CcSEcCtD
Indomethacin—Gastritis—Lisinopril—dilated cardiomyopathy	0.000649	0.00477	CcSEcCtD
Indomethacin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00064	0.0047	CcSEcCtD
Indomethacin—Asthma—Lisinopril—dilated cardiomyopathy	0.000634	0.00466	CcSEcCtD
Indomethacin—Tinnitus—Furosemide—dilated cardiomyopathy	0.000631	0.00463	CcSEcCtD
Indomethacin—ABCC1—cardiac atrium—dilated cardiomyopathy	0.000625	0.00866	CbGeAlD
Indomethacin—Pruritus—Spironolactone—dilated cardiomyopathy	0.000625	0.00459	CcSEcCtD
Indomethacin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000604	0.00444	CcSEcCtD
Indomethacin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000604	0.00444	CcSEcCtD
Indomethacin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000602	0.00442	CcSEcCtD
Indomethacin—Erythema—Furosemide—dilated cardiomyopathy	0.000589	0.00433	CcSEcCtD
Indomethacin—Dizziness—Spironolactone—dilated cardiomyopathy	0.000584	0.00429	CcSEcCtD
Indomethacin—Flatulence—Furosemide—dilated cardiomyopathy	0.00058	0.00426	CcSEcCtD
Indomethacin—Weight increased—Lisinopril—dilated cardiomyopathy	0.000577	0.00424	CcSEcCtD
Indomethacin—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000572	0.0042	CcSEcCtD
Indomethacin—Depression—Lisinopril—dilated cardiomyopathy	0.000564	0.00414	CcSEcCtD
Indomethacin—Vomiting—Spironolactone—dilated cardiomyopathy	0.000562	0.00413	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000561	0.00412	CcSEcCtD
Indomethacin—Rash—Spironolactone—dilated cardiomyopathy	0.000557	0.00409	CcSEcCtD
Indomethacin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000556	0.00409	CcSEcCtD
Indomethacin—Renal failure—Lisinopril—dilated cardiomyopathy	0.000556	0.00408	CcSEcCtD
Indomethacin—Vision blurred—Furosemide—dilated cardiomyopathy	0.000555	0.00408	CcSEcCtD
Indomethacin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000554	0.00407	CcSEcCtD
Indomethacin—Headache—Spironolactone—dilated cardiomyopathy	0.000553	0.00407	CcSEcCtD
Indomethacin—CYP2C9—heart—dilated cardiomyopathy	0.000553	0.00766	CbGeAlD
Indomethacin—Jaundice—Lisinopril—dilated cardiomyopathy	0.000551	0.00405	CcSEcCtD
Indomethacin—Anaemia—Furosemide—dilated cardiomyopathy	0.000544	0.004	CcSEcCtD
Indomethacin—Sweating—Lisinopril—dilated cardiomyopathy	0.000542	0.00398	CcSEcCtD
Indomethacin—Haematuria—Lisinopril—dilated cardiomyopathy	0.000539	0.00396	CcSEcCtD
Indomethacin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000533	0.00392	CcSEcCtD
Indomethacin—Vertigo—Furosemide—dilated cardiomyopathy	0.000529	0.00389	CcSEcCtD
Indomethacin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000528	0.00388	CcSEcCtD
Indomethacin—Leukopenia—Furosemide—dilated cardiomyopathy	0.000527	0.00387	CcSEcCtD
Indomethacin—Nausea—Spironolactone—dilated cardiomyopathy	0.000525	0.00385	CcSEcCtD
Indomethacin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000517	0.0038	CcSEcCtD
Indomethacin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000508	0.00373	CcSEcCtD
Indomethacin—PTGS1—heart—dilated cardiomyopathy	0.000505	0.007	CbGeAlD
Indomethacin—Confusional state—Furosemide—dilated cardiomyopathy	0.000485	0.00356	CcSEcCtD
Indomethacin—PTGS2—heart—dilated cardiomyopathy	0.000482	0.00669	CbGeAlD
Indomethacin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000481	0.00353	CcSEcCtD
Indomethacin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00048	0.00353	CcSEcCtD
Indomethacin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000473	0.00348	CcSEcCtD
Indomethacin—Shock—Furosemide—dilated cardiomyopathy	0.000473	0.00347	CcSEcCtD
Indomethacin—Flushing—Lisinopril—dilated cardiomyopathy	0.000471	0.00346	CcSEcCtD
Indomethacin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000471	0.00346	CcSEcCtD
Indomethacin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000465	0.00341	CcSEcCtD
Indomethacin—Anorexia—Furosemide—dilated cardiomyopathy	0.000458	0.00337	CcSEcCtD
Indomethacin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000453	0.00333	CcSEcCtD
Indomethacin—Hypotension—Furosemide—dilated cardiomyopathy	0.000449	0.0033	CcSEcCtD
Indomethacin—Alopecia—Lisinopril—dilated cardiomyopathy	0.000449	0.00329	CcSEcCtD
Indomethacin—Erythema—Lisinopril—dilated cardiomyopathy	0.000442	0.00325	CcSEcCtD
Indomethacin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000435	0.0032	CcSEcCtD
Indomethacin—Tension—Lisinopril—dilated cardiomyopathy	0.000434	0.00319	CcSEcCtD
Indomethacin—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000432	0.00598	CbGeAlD
Indomethacin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000432	0.00317	CcSEcCtD
Indomethacin—Nervousness—Lisinopril—dilated cardiomyopathy	0.000429	0.00315	CcSEcCtD
Indomethacin—Somnolence—Furosemide—dilated cardiomyopathy	0.000427	0.00314	CcSEcCtD
Indomethacin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000418	0.00307	CcSEcCtD
Indomethacin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000416	0.00306	CcSEcCtD
Indomethacin—Fatigue—Furosemide—dilated cardiomyopathy	0.000414	0.00304	CcSEcCtD
Indomethacin—Pain—Furosemide—dilated cardiomyopathy	0.000411	0.00302	CcSEcCtD
Indomethacin—Constipation—Furosemide—dilated cardiomyopathy	0.000411	0.00302	CcSEcCtD
Indomethacin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00041	0.00301	CcSEcCtD
Indomethacin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000408	0.003	CcSEcCtD
Indomethacin—Angioedema—Lisinopril—dilated cardiomyopathy	0.000404	0.00297	CcSEcCtD
Indomethacin—Malaise—Lisinopril—dilated cardiomyopathy	0.000398	0.00293	CcSEcCtD
Indomethacin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000397	0.00292	CcSEcCtD
Indomethacin—Syncope—Lisinopril—dilated cardiomyopathy	0.000396	0.00291	CcSEcCtD
Indomethacin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000396	0.00291	CcSEcCtD
Indomethacin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000396	0.00291	CcSEcCtD
Indomethacin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000393	0.00289	CcSEcCtD
Indomethacin—Palpitations—Lisinopril—dilated cardiomyopathy	0.00039	0.00287	CcSEcCtD
Indomethacin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000388	0.00285	CcSEcCtD
Indomethacin—Urticaria—Furosemide—dilated cardiomyopathy	0.000382	0.0028	CcSEcCtD
Indomethacin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00038	0.00279	CcSEcCtD
Indomethacin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00038	0.00279	CcSEcCtD
Indomethacin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000376	0.00276	CcSEcCtD
Indomethacin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000375	0.00275	CcSEcCtD
Indomethacin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000372	0.00273	CcSEcCtD
Indomethacin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000364	0.00267	CcSEcCtD
Indomethacin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000361	0.00265	CcSEcCtD
Indomethacin—Oedema—Lisinopril—dilated cardiomyopathy	0.000361	0.00265	CcSEcCtD
Indomethacin—Shock—Lisinopril—dilated cardiomyopathy	0.000355	0.00261	CcSEcCtD
Indomethacin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000354	0.0026	CcSEcCtD
Indomethacin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000353	0.00259	CcSEcCtD
Indomethacin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000352	0.00259	CcSEcCtD
Indomethacin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000349	0.00256	CcSEcCtD
Indomethacin—Asthenia—Furosemide—dilated cardiomyopathy	0.000345	0.00253	CcSEcCtD
Indomethacin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000344	0.00253	CcSEcCtD
Indomethacin—Pruritus—Furosemide—dilated cardiomyopathy	0.00034	0.0025	CcSEcCtD
Indomethacin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000337	0.00248	CcSEcCtD
Indomethacin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000329	0.00242	CcSEcCtD
Indomethacin—Insomnia—Lisinopril—dilated cardiomyopathy	0.000326	0.0024	CcSEcCtD
Indomethacin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000324	0.00238	CcSEcCtD
Indomethacin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000322	0.00236	CcSEcCtD
Indomethacin—Somnolence—Lisinopril—dilated cardiomyopathy	0.000321	0.00235	CcSEcCtD
Indomethacin—Dizziness—Furosemide—dilated cardiomyopathy	0.000318	0.00233	CcSEcCtD
Indomethacin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000317	0.00233	CcSEcCtD
Indomethacin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000313	0.0023	CcSEcCtD
Indomethacin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000311	0.00228	CcSEcCtD
Indomethacin—Pain—Lisinopril—dilated cardiomyopathy	0.000308	0.00227	CcSEcCtD
Indomethacin—Constipation—Lisinopril—dilated cardiomyopathy	0.000308	0.00227	CcSEcCtD
Indomethacin—Vomiting—Furosemide—dilated cardiomyopathy	0.000306	0.00224	CcSEcCtD
Indomethacin—Rash—Furosemide—dilated cardiomyopathy	0.000303	0.00223	CcSEcCtD
Indomethacin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000303	0.00222	CcSEcCtD
Indomethacin—Headache—Furosemide—dilated cardiomyopathy	0.000301	0.00221	CcSEcCtD
Indomethacin—ABCB1—heart—dilated cardiomyopathy	0.000298	0.00414	CbGeAlD
Indomethacin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000297	0.00218	CcSEcCtD
Indomethacin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000295	0.00217	CcSEcCtD
Indomethacin—Urticaria—Lisinopril—dilated cardiomyopathy	0.000286	0.0021	CcSEcCtD
Indomethacin—Nausea—Furosemide—dilated cardiomyopathy	0.000285	0.0021	CcSEcCtD
Indomethacin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000285	0.00209	CcSEcCtD
Indomethacin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000285	0.00209	CcSEcCtD
Indomethacin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000266	0.00195	CcSEcCtD
Indomethacin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000259	0.0019	CcSEcCtD
Indomethacin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000255	0.00187	CcSEcCtD
Indomethacin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000247	0.00181	CcSEcCtD
Indomethacin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000238	0.00175	CcSEcCtD
Indomethacin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000229	0.00168	CcSEcCtD
Indomethacin—Rash—Lisinopril—dilated cardiomyopathy	0.000227	0.00167	CcSEcCtD
Indomethacin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000227	0.00167	CcSEcCtD
Indomethacin—Headache—Lisinopril—dilated cardiomyopathy	0.000226	0.00166	CcSEcCtD
Indomethacin—Nausea—Lisinopril—dilated cardiomyopathy	0.000214	0.00157	CcSEcCtD
Indomethacin—PPARA—Gene Expression—NPPA—dilated cardiomyopathy	6.15e-05	0.000501	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	6.13e-05	0.0005	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.12e-05	0.000499	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.86e-05	0.000477	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—RAC1—dilated cardiomyopathy	5.85e-05	0.000477	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.83e-05	0.000475	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.83e-05	0.000475	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	5.83e-05	0.000475	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.8e-05	0.000473	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.76e-05	0.000469	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	5.75e-05	0.000469	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	5.75e-05	0.000469	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.7e-05	0.000464	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—AGT—dilated cardiomyopathy	5.58e-05	0.000455	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.55e-05	0.000452	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	5.55e-05	0.000452	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	5.51e-05	0.000449	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.42e-05	0.000442	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	5.4e-05	0.00044	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.39e-05	0.000439	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.29e-05	0.000431	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.29e-05	0.000431	CbGpPWpGaD
Indomethacin—PPARG—Adipogenesis—TNF—dilated cardiomyopathy	5.29e-05	0.000431	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.28e-05	0.00043	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	5.27e-05	0.000429	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	5.26e-05	0.000429	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.25e-05	0.000428	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.24e-05	0.000427	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.24e-05	0.000427	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—ITGB1—dilated cardiomyopathy	5.22e-05	0.000425	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	5.18e-05	0.000422	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.1e-05	0.000416	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	5.09e-05	0.000415	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.09e-05	0.000415	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	5.06e-05	0.000412	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.03e-05	0.00041	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	5.03e-05	0.00041	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.99e-05	0.000407	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.99e-05	0.000407	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.92e-05	0.000401	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.87e-05	0.000397	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.77e-05	0.000388	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.72e-05	0.000385	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	4.69e-05	0.000382	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.59e-05	0.000374	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.59e-05	0.000374	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VCL—dilated cardiomyopathy	4.59e-05	0.000374	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.55e-05	0.00037	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.48e-05	0.000365	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.46e-05	0.000364	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—CD36—dilated cardiomyopathy	4.45e-05	0.000363	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—NPPA—dilated cardiomyopathy	4.41e-05	0.000359	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	4.38e-05	0.000357	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—AGT—dilated cardiomyopathy	4.34e-05	0.000354	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	4.34e-05	0.000354	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.32e-05	0.000352	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.27e-05	0.000348	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.25e-05	0.000347	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.2e-05	0.000343	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—RAC1—dilated cardiomyopathy	4.19e-05	0.000342	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	4.12e-05	0.000335	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	4.09e-05	0.000333	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	4.09e-05	0.000333	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.08e-05	0.000333	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.07e-05	0.000332	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.02e-05	0.000327	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—GPX1—dilated cardiomyopathy	4e-05	0.000326	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.98e-05	0.000324	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.96e-05	0.000323	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.96e-05	0.000323	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—AGT—dilated cardiomyopathy	3.93e-05	0.00032	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—CD36—dilated cardiomyopathy	3.9e-05	0.000318	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—RAF1—dilated cardiomyopathy	3.88e-05	0.000316	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.86e-05	0.000315	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	3.81e-05	0.000311	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.79e-05	0.000308	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.76e-05	0.000306	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.74e-05	0.000305	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	3.72e-05	0.000303	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.69e-05	0.0003	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.66e-05	0.000298	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.61e-05	0.000294	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	3.59e-05	0.000293	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.58e-05	0.000292	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.57e-05	0.000291	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	3.54e-05	0.000289	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.54e-05	0.000288	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.52e-05	0.000287	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AGT—dilated cardiomyopathy	3.51e-05	0.000286	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.51e-05	0.000286	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.5e-05	0.000285	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.42e-05	0.000278	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—GPX1—dilated cardiomyopathy	3.4e-05	0.000277	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NPPA—dilated cardiomyopathy	3.39e-05	0.000276	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.38e-05	0.000276	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	3.33e-05	0.000272	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TAZ—dilated cardiomyopathy	3.33e-05	0.000271	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—CD36—dilated cardiomyopathy	3.31e-05	0.00027	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.31e-05	0.00027	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.3e-05	0.000269	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.3e-05	0.000269	CbGpPWpGaD
Indomethacin—PPARA—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.3e-05	0.000269	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.29e-05	0.000268	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PSEN2—dilated cardiomyopathy	3.28e-05	0.000268	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	3.25e-05	0.000265	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.21e-05	0.000262	CbGpPWpGaD
Indomethacin—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.21e-05	0.000262	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—RAC1—dilated cardiomyopathy	3.21e-05	0.000261	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	3.18e-05	0.000259	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	3.18e-05	0.000259	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.15e-05	0.000257	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.13e-05	0.000255	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.13e-05	0.000255	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.13e-05	0.000255	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.1e-05	0.000253	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.1e-05	0.000253	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.08e-05	0.000251	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.05e-05	0.000248	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.01e-05	0.000246	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SDHA—dilated cardiomyopathy	3.01e-05	0.000245	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—RAC1—dilated cardiomyopathy	3e-05	0.000244	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	2.99e-05	0.000244	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AGT—dilated cardiomyopathy	2.98e-05	0.000243	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.97e-05	0.000242	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—GPX1—dilated cardiomyopathy	2.93e-05	0.000238	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	2.92e-05	0.000238	CbGpPWpGaD
Indomethacin—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.91e-05	0.000238	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.91e-05	0.000237	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.9e-05	0.000236	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.89e-05	0.000236	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AGT—dilated cardiomyopathy	2.86e-05	0.000233	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.86e-05	0.000233	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—CD36—dilated cardiomyopathy	2.85e-05	0.000232	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.82e-05	0.00023	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.82e-05	0.000229	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.78e-05	0.000227	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—RAF1—dilated cardiomyopathy	2.78e-05	0.000227	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.73e-05	0.000222	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	2.71e-05	0.000221	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.7e-05	0.00022	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—EGFR—dilated cardiomyopathy	2.66e-05	0.000217	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.64e-05	0.000215	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AGT—dilated cardiomyopathy	2.57e-05	0.000209	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—GPX1—dilated cardiomyopathy	2.54e-05	0.000207	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TNF—dilated cardiomyopathy	2.53e-05	0.000207	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.51e-05	0.000204	CbGpPWpGaD
Indomethacin—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.5e-05	0.000204	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.49e-05	0.000203	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—CD36—dilated cardiomyopathy	2.47e-05	0.000201	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.46e-05	0.000201	CbGpPWpGaD
Indomethacin—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.45e-05	0.0002	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.4e-05	0.000196	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	2.38e-05	0.000194	CbGpPWpGaD
Indomethacin—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.35e-05	0.000191	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.35e-05	0.000191	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	2.3e-05	0.000188	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.28e-05	0.000186	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NPPA—dilated cardiomyopathy	2.27e-05	0.000185	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.27e-05	0.000185	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.27e-05	0.000185	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RAC1—dilated cardiomyopathy	2.25e-05	0.000183	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AGT—dilated cardiomyopathy	2.22e-05	0.000181	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.21e-05	0.00018	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PSEN2—dilated cardiomyopathy	2.2e-05	0.00018	CbGpPWpGaD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.18e-05	0.000177	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.16e-05	0.000176	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AGT—dilated cardiomyopathy	2.15e-05	0.000175	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—RAF1—dilated cardiomyopathy	2.13e-05	0.000173	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.07e-05	0.000168	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.04e-05	0.000167	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.99e-05	0.000162	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.99e-05	0.000162	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.98e-05	0.000161	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.96e-05	0.00016	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.96e-05	0.00016	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.96e-05	0.00016	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	1.92e-05	0.000157	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	1.92e-05	0.000157	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—EGFR—dilated cardiomyopathy	1.91e-05	0.000155	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CD36—dilated cardiomyopathy	1.87e-05	0.000153	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	1.87e-05	0.000153	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.86e-05	0.000152	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—RAC1—dilated cardiomyopathy	1.85e-05	0.000151	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.84e-05	0.00015	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GPX1—dilated cardiomyopathy	1.82e-05	0.000148	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TNF—dilated cardiomyopathy	1.82e-05	0.000148	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.79e-05	0.000146	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RAC1—dilated cardiomyopathy	1.77e-05	0.000144	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CD36—dilated cardiomyopathy	1.77e-05	0.000144	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AGT—dilated cardiomyopathy	1.69e-05	0.000138	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	1.69e-05	0.000137	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AGT—dilated cardiomyopathy	1.69e-05	0.000137	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	1.67e-05	0.000136	CbGpPWpGaD
Indomethacin—ABCC1—Disease—RAC1—dilated cardiomyopathy	1.65e-05	0.000135	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.65e-05	0.000134	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	1.63e-05	0.000133	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.61e-05	0.000131	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.61e-05	0.000131	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.61e-05	0.000131	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AGT—dilated cardiomyopathy	1.59e-05	0.00013	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	1.56e-05	0.000127	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	1.56e-05	0.000127	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.53e-05	0.000125	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	1.52e-05	0.000124	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	1.52e-05	0.000124	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	1.51e-05	0.000123	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.5e-05	0.000123	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.49e-05	0.000121	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	1.47e-05	0.00012	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CD36—dilated cardiomyopathy	1.47e-05	0.00012	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.46e-05	0.000119	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EGFR—dilated cardiomyopathy	1.46e-05	0.000119	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.45e-05	0.000118	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	1.43e-05	0.000117	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	1.39e-05	0.000114	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	1.37e-05	0.000112	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	1.37e-05	0.000112	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.36e-05	0.000111	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AGT—dilated cardiomyopathy	1.32e-05	0.000108	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.32e-05	0.000107	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	1.27e-05	0.000104	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	1.26e-05	0.000102	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CD36—dilated cardiomyopathy	1.24e-05	0.000101	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.23e-05	0.0001	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RAF1—dilated cardiomyopathy	1.17e-05	9.57e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AGT—dilated cardiomyopathy	1.12e-05	9.1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RAC1—dilated cardiomyopathy	1.11e-05	9.03e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—RAF1—dilated cardiomyopathy	1.09e-05	8.92e-05	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.06e-05	8.66e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.02e-05	8.32e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	1.01e-05	8.24e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CD36—dilated cardiomyopathy	9.85e-06	8.02e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.31e-06	7.59e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AGT—dilated cardiomyopathy	8.86e-06	7.22e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPX1—dilated cardiomyopathy	8.18e-06	6.67e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—dilated cardiomyopathy	8.05e-06	6.56e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CD36—dilated cardiomyopathy	7.97e-06	6.49e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—dilated cardiomyopathy	7.51e-06	6.12e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RAF1—dilated cardiomyopathy	7.35e-06	5.99e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	7.34e-06	5.98e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AGT—dilated cardiomyopathy	7.17e-06	5.84e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	7.17e-06	5.84e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	7.15e-06	5.83e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	6.98e-06	5.69e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	6.69e-06	5.46e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	6.52e-06	5.31e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	6.44e-06	5.25e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	6.28e-06	5.12e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.87e-06	4.78e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—dilated cardiomyopathy	5.04e-06	4.11e-05	CbGpPWpGaD
